A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer
Clinical trial NCT05482568 · RECRUITING
Trial details
- NCT number
- NCT05482568
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-15
- Primary completion
- 2026-12-01
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.